Brief: Athenex Says Klisyri Received Positive CHMP Opinion From EMA
21/05/2021 14:27
May 21 (Reuters) - Athenex Inc ATNX.O :
* ATHENEX ANNOUNCES KLISYRI® (TIRBANIBULIN) RECEIVES
POSITIVE CHMP
OPINION FROM THE EUROPEAN MEDICINES AGENCY (EMA) FOR THE
TREATMENT OF ACTINIC KERATOSIS OF THE FACE OR SCALP
Source text for Eikon: ID:nGNX9fpnm9
Further company coverage: ATNX.O
((Reuters.Briefs@thomsonreuters.com;))